Sun Pharmaceutical Industries Ltd. — Investor Relations & Filings
Sun Pharmaceutical Industries Ltd. is a global leader in specialty generic pharmaceuticals, focused on developing, manufacturing, and marketing a comprehensive range of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company’s extensive portfolio covers diverse therapeutic segments, including cardiology, psychiatry, neurology, gastroenterology, ophthalmology, dermatology, and orthopedics. It provides high-quality, affordable medicines across more than 100 markets worldwide, serving both chronic and acute care needs. A significant emphasis is placed on research and development to produce complex generics and innovative specialty products. The organization maintains a robust global manufacturing footprint, operating facilities that comply with stringent international regulatory standards. Its offerings encompass generics, branded generics, specialty medications, and over-the-counter products, aimed at improving patient outcomes globally.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Change in Auditors | 2025-05-22 | English | |
| Dividend | 2025-05-22 | English | |
| Change in Director(s) | 2025-05-22 | English | |
| Outcome of Board Meeting | 2025-05-22 | English | |
| Analysts/Institutional Investor Meet/Con. Call Updates | 2025-05-20 | English | |
| Press Release | 2025-05-16 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 42335957 | Change in Auditors | 2025-05-22 | English | ||
| 42336707 | Dividend | 2025-05-22 | English | ||
| 42336858 | Change in Director(s) | 2025-05-22 | English | ||
| 42336974 | Outcome of Board Meeting | 2025-05-22 | English | ||
| 42371873 | Analysts/Institutional Investor Meet/Con. Call Updates | 2025-05-20 | English | ||
| 42428843 | Press Release | 2025-05-16 | English | ||
| 42416818 | Press Release | 2025-05-12 | English | ||
| 43893645 | Board Meeting — Board Meeting Intimation | 2025-05-12 | English | ||
| 43893669 | Board Meeting — Financial Results/Dividend | 2025-05-12 | English | ||
| 42369259 | Press Release | 2025-05-08 | English | ||
| 42387553 | Change in Management | 2025-05-06 | English | ||
| 42370716 | Press Release | 2025-04-24 | English | ||
| 42386742 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2025-04-14 | English | ||
| 42370678 | General Updates | 2025-04-10 | English | ||
| 42381010 | Disclosure under SEBI Takeover Regulations | 2025-04-08 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Sun Pharmaceutical Industries Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/59215/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=59215 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=59215 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=59215 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 59215}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Sun Pharmaceutical Industries Ltd. (id: 59215)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.